IntelliPharmaCeutics International (IntelliPharmaCeutics International) Price-to-Tangible-Book : (As of Apr. 27, 2024)

View and export this data going back to 1996. Start your Free Trial

What is IntelliPharmaCeutics International Price-to-Tangible-Book?

As of today (2024-04-27), IntelliPharmaCeutics International's share price is $0.06. IntelliPharmaCeutics International's Tangible Book per Share of Aug. 2023 for the quarter that ended in Aug. 2023 was $-0.39. Hence, IntelliPharmaCeutics International's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for IntelliPharmaCeutics International's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, IntelliPharmaCeutics International's highest Price to Tangible Book Ratio was 88.39. The lowest was 1.52. And the median was 18.90.

IPCIF's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.65
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, IntelliPharmaCeutics International's share price is $0.06. IntelliPharmaCeutics International's Book Value per Sharefor the quarter that ended in Aug. 2023 was $-0.39. Hence, IntelliPharmaCeutics International's P/B Ratio of today is .

IntelliPharmaCeutics International Price-to-Tangible-Book Historical Data

The historical data trend for IntelliPharmaCeutics International's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International Price-to-Tangible-Book Chart

IntelliPharmaCeutics International Annual Data

Trend

Nov13

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Price-to-Tangible-Book

Get a 7-Day Free Trial

1.47

IntelliPharmaCeutics International Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of IntelliPharmaCeutics International's Price-to-Tangible-Book

For the Biotechnology subindustry, IntelliPharmaCeutics International's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IntelliPharmaCeutics International's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's Price-to-Tangible-Book falls into.

IntelliPharmaCeutics International Price-to-Tangible-Book Calculation

IntelliPharmaCeutics International's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Aug. 2023 )
	=	0.06	/	-0.389
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

IntelliPharmaCeutics International Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

IntelliPharmaCeutics International (IntelliPharmaCeutics International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (OTCPK:IPCIF) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

I4AA:Germany IPCI:Canada

Address

30 Worcester Road, Toronto, ON, CAN, M9W 5X2

Website

https://www.intellipharmaceutics.com

IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.